The secretome of hydrogel-coembedded endothelial progenitor cells and mesenchymal stem cells instructs macrophage polarization in endotoxemia

Stem Cells Translational Medicine

Volumn 4, Issue 7, 2015, Pages 852-861

  Zullo, Joseph A ^a   Nadel, Ellen P ^a   Rabadi, May M ^a   Baskind, Matthew J ^a   Rajdev, Maharshi A ^a   Demaree, Cameron M ^a   Vasko, Radovan ^a,b   Chugh, Savneek S ^a   Lamba, Rajat ^a   Goligorsky, Michael S ^a   Ratliff, Brian B ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Acute kidney injury; Endothelial progenitor cells; Hyaluronic acid hydrogel; Lipopolysaccharide; Macrophage polarization; Mesenchymal stem cells

Indexed keywords

ALBUMIN; ARGINASE 1; CREATININE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYALURONIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL HYPOXIA; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIAL PROGENITOR CELL; EXPERIMENTAL SEPSIS; FLOW CYTOMETRY; HYDROGEL; INFLAMMATION; KIDNEY FUNCTION; LASER DOPPLER FLOWMETRY; LIPOPOLYSACCHARIDE-INDUCED ENDOTOXEMIA; MACROPHAGE ACTIVATION; MALE; MEAN ARTERIAL PRESSURE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; POLARIZATION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION;

MUS;

EID: 84937010878     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0111     Document Type: Article

References (52)

1. Ghaly T, Rabadi MM, Weber M et al. Hydrogel-embedded endothelial progenitor cells evade LPS andmitigate endotoxemia. AmJ Physiol Renal Physiol 2011; 301: F802-F812.
2. Kale S, Karihaloo A, Clark PR et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 2003; 112: 42-49.
3. Morigi M, Introna M, Imberti B et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. STEM CELLS 2008; 26: 2075-2082.
4. Park HC, Yasuda K, Ratliff B et al. Postobstructive regenerationof kidney isderailedwhen surge in renal stem cells during course of unilateral ureteral obstruction is halted. Am J Physiol Renal Physiol 2010; 298: F357-F364.
5. Patschan D, Plotkin M, Goligorsky MS. Therapeutic use of stem and endothelial progenitor cells in acute renal injury: Ça ira. Curr Opin Pharmacol 2006; 6: 176-183.
6. Ratliff BB, Ghaly T, Brudnicki P et al. Endothelial progenitors encapsulated in bioartificial niches are insulated from systemic cytotoxicity and are angiogenesis competent. Am J Physiol Renal Physiol 2010; 299: F178-F186.
7. Yasuda K, Park HC, Ratliff B et al. Adriamycin nephropathy: A failure of endothelial progenitor cell-induced repair. Am J Pathol 2010; 176: 1685-1695.
8. Asahara T, MuroharaT, SullivanAet al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
9. Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-3427.
10. Minamino T, Miyauchi H, Yoshida T et al. Endothelial cell senescence in human atherosclerosis: Role of telomere in endothelial dysfunction. Circulation 2002; 105: 1541-1544.
11. Goligorsky MS, Yasuda K, Ratliff B. Dysfunctional endothelial progenitor cells in chronic kidney disease. J Am Soc Nephrol 2010; 21: 911-919.
12. Young PP, Vaughan DE, Hatzopoulos AK. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis 2007; 49: 421-429.
13. Caiado F, Dias S. Endothelial progenitor cells and integrins: Adhesive needs. Fibrogenesis Tissue Repair 2012; 5: 4.
14. Burdick JA, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater 2011; 23: H41-H56.
15. Levenberg S, Burdick JA, Kraehenbuehl T et al. Neurotrophin-induced differentiation of human embryonic stem cells on three-dimensional polymeric scaffolds. Tissue Eng 2005; 11: 506-512.
16. Zhang J, Skardal A, Prestwich GD. Engineered extracellularmatriceswith cleavable crosslinkers for cell expansion and easy cell recovery. Biomaterials 2008; 29: 4521-4531.
17. Bailey AS, Jiang S, Afentoulis M et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 2004; 103: 13-19.
18. Vasa M, Fichtlscherer S, Aicher A et al. Numberand migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
19. Ranganath SH, Levy O, Inamdar MS et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012; 10: 244-258.
20. Hatzopoulos AK, Folkman J, Vasile E et al. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 1998; 125: 1457-1468.
21. PlotkinMD, GoligorskyMS. Mesenchymal cells fromadult kidney support angiogenesis and differentiate intomultiple interstitial cell types including erythropoietin-producing fibroblasts. Am J Physiol Renal Physiol 2006; 291: F902-F912.
22. Chacko SM, Ahmed S, Selvendiran K et al. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol 2010; 299: C1562-C1570.
23. Hu X, Yu SP, Fraser JL et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 2008; 135: 799-808.
24. Ohnishi S, Yasuda T, Kitamura S et al. Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. STEM CELLS 2007; 25: 1166-1177.
25. de Broucker V, Hassoun SM, Hulo S et al. Non-invasive collection of exhaled breath condensate in rats: Evaluation of pH, H2O2 and NOx in lipopolysaccharide-induced acute lung injury. Vet J 2012; 194: 222-228.
26. Gorąca A, Huk-Kolega H, Kleniewska P et al. Effects of lipoic acid on spleen oxidative stress after LPS administration. Pharmacol Rep 2013; 65: 179-186.
27. Kavoosi G, Teixeira da Silva JA, Saharkhiz MJ. Inhibitory effects of Zataria multiflora essential oil and its main components on nitric oxide and hydrogen peroxide production in lipopolysaccharide-stimulated macrophages. J Pharm Pharmacol 2012; 64: 1491-1500.
28. Kim HJ, Kim SR, Park JK et al. PI3Kg activation is required for LPS-induced reactive oxygen species generation in respiratory epithelial cells. Inflamm Res 2012; 61: 1265-1272.
29. Pai K, Sodhi A. Effect of cisplatin, rIFN-Y, LPS and MDP on release of H2O2, O2-and lysozyme from human monocytes in vitro. Indian J Exp Biol 1991; 29: 910-915.
30. Sodhi A, Geetha B. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. II. Production of H2O2, O2-and interleukin-1. Nat Immun Cell Growth Regul 1989; 8: 108-116.
31. Sodhi A, Gupta P. Increased release of hydrogen peroxide (H2O2) and superoxide anion (O2-) by murine macrophages in vitro after cisplatin treatment. Int J Immunopharmacol 1986; 8: 709-714.
32. Gordon S, Martinez FO. Alternative activation of macrophages: Mechanism and functions. Immunity 2010; 32: 593-604.
33. Shi Y, Su J, Roberts AI et al. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 2012; 33: 136-143.
34. Maggini J, Mirkin G, Bognanni I et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-likeprofile. PLoSOne 2010; 5: e9252.
35. Mantovani A, Biswas SK, Galdiero MR et al. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229: 176-185.
36. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118: 3522-3530.
37. Arnold L, Henry A, Poron F et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007; 204: 1057-1069.
38. Németh K, Leelahavanichkul A, Yuen PS et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10. production. Nat Med 2009; 15: 42-49.
39. KimJ, Hematti P. Mesenchymal stem celleducated macrophages: Anovel type of alternatively activated macrophages. Exp Hematol 2009; 37: 1445-1453.
40. Dayan V, Yannarelli G, Billia F et al. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res Cardiol 2011; 106: 1299-1310.
41. English K, Ryan JM, Tobin L et al. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin Exp Immunol 2009; 156: 149-160.
42. Maccario R, Podestà M, Moretta A et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/-suppressive phenotype. Haematologica 2005; 90: 516-525.
43. Melief SM, Schrama E, Brugman MH et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward antiinflammatory macrophages. STEM CELLS 2013; 31: 1980-1991.
44. Chinetti-Gbaguidi G, Staels B. Macrophage polarization in metabolic disorders: Functions and regulation. Curr Opin Lipidol 2011; 22: 365-372.
45. Lee S, Huen S, NishioHet al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 2011; 22: 317-326.
46. Seib FP, Prewitz M, Werner C et al. Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs). Biochem Biophys Res Commun 2009; 389: 663-667.
47. Franke K, Pompe T, Bornhäuser M et al. Engineered matrix coatings to modulate the adhesion of CD133+ human hematopoietic progenitor cells. Biomaterials 2007; 28: 836-843.
48. Li YJ, Chung EH, Rodriguez RT et al. Hydrogels as artificial matrices for human embryonic stem cell self-renewal. J Biomed Mater Res A 2006; 79: 1-5.
49. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-2213.
50. Pelekanos RA, Li J, Gongora M et al. Comprehensive transcriptomeand immunophenotype analysis of renal and cardiacMSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities. Stem Cell Res (Amst) 2012; 8: 58-73.
51. Morigi M, Benigni A. Mesenchymal stem cells and kidney repair. Nephrol Dial Transplant 2013; 28: 788-793.
52. Chen J, Park HC, Addabbo F et al. Kidneyderived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int 2008; 74: 879-889.